Xarelto is a drug produced by Bayer Pharmaceuticals that was designed to work on blood thinning and blood clot prevention. Patients who took Xarelto were supposed to benefit from the drug within hours. It was granted approval in 2011 to be used in hip and knee replacement surgeries in order to prevent embolisms and thrombosis. It later allowed Johnson & Johnson to market it for different purposes.
Xarelto was marketed as an alternative to Warfarin, which was the conventional blood thinner drug. Warfarin has an antidote that can reverse the drug’s effects in the event that the patient bleeds too profusely.
Patients who took Xarelto began experiencing serious side effects. One was a risk of severe bleeds, some of which could not be stopped or reversed, because unlike Warfarin, Xarelto did not have an antidote. Some other serious side effects are an increased risk of stroke, a risk of paralysis in patients who receive a spinal tap while taking Xarelto, and an increased risk of a blood clot after stopping Xarelto.
In 2013 and 2014, the FDA warned Johnson & Johnson that it had been misleading in its advertising of Xarelto, and it forced the company to highlight certain side effects of the drug. However, the company has refused to completely recall the drug and it is still on the market today.
If you or a loved one has been harmed by Xarelto, you should speak with an attorney. You may be eligible for compensation. Call today to learn more or to schedule your free consultation.